Gordius

Gordius is a prescription medication that contains the active ingredient gabapentin, an anticonvulsant classified as an antiepileptic drug. It is supplied in oral form and marketed in the European Union. The product is used under medical supervision for several neurological conditions, and it is not a controlled substance. It is manufactured without a specific brand name and does not contain additional active compounds for therapeutic use.

Gordius (gabapentin) is prescribed for several neurological and pain‑related conditions that are approved for use in the European Union.

- Adjunctive therapy for focal (partial) seizures in epilepsy. - Management of neuropathic pain associated with diabetic peripheral neuropathy. - Treatment of postherpetic neuralgia to reduce pain after shingles. - Relief of symptoms in restless legs syndrome. - Off‑label use for certain anxiety disorders under specialist supervision.

Side effects of gabapentin may vary in frequency and severity, and they are typically reported by patients taking Gordius.

Common: - Dizziness - Fatigue - Somnolence - Peripheral edema

Serious: - Severe allergic reactions such as Stevens‑Johnson syndrome - Suicidal thoughts or behavior - Respiratory depression, especially when combined with other depressants

Before starting Gordius, clinicians should evaluate several safety considerations to minimize risks.

- Adjust dose in patients with renal impairment. - Pregnancy and breastfeeding status are unknown; use only if benefits outweigh risks. - Monitor for mood changes or suicidal ideation. - Review history of psychiatric disorders before initiation. - Avoid abrupt discontinuation to reduce seizure recurrence. - Use lower initial doses in elderly patients due to increased sensitivity.

Gabapentin can interact with other medicines, and some combinations should be avoided while others require careful monitoring.

Avoid: - Antacids containing aluminum or magnesium, which can reduce gabapentin absorption. - Opioid analgesics, because combined use may increase central nervous system depression. - Alcohol, due to additive sedative effects.

Use with caution: - Other central nervous system depressants such as benzodiazepines or barbiturates. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) in patients with renal dysfunction. - ACE inhibitors or angiotensin receptor blockers, which may affect renal clearance. - Loop or thiazide diuretics, as they can alter gabapentin excretion.